Fasting glucose improved within weeks and my HbA1c barely moved for three months, which I now understand and did not at the time.
What I am after is why A1C lags the way it does, and what to look at in the meantime if you want to know sooner.
Tell me what I have not thought of.
CryptoCarl said:Fasting glucose improved within weeks and my HbA1c barely moved for three months, which I now understand and did not at the time.
PCOS success story with glycaemic control: as someone with polycystic ovary syndrome, this medication has been transformative beyond weight loss.
After 11 months: periods became regular for the first time in a decade, testosterone levels normalized, acne cleared significantly, and — unexpectedly — my fertility specialist is optimistic about future conception.
GLP-1 agonists address the insulin resistance at the root of PCOS. For PCOS patients, this isn't "just" a weight loss drug — it's treating our underlying metabolic dysfunction.
LarryQC_SD said:PCOS success story with glycaemic control: as someone with polycystic ovary syndrome, this medication has been transformative beyond weight loss.
Fasting insulin is the lab my functional medicine doctor cares about most for glycaemic control: it's a much earlier marker of metabolic dysfunction than glucose or A1C.
My fasting insulin: 30 → 14 → 5 uIU/mL over 9 months. Target is <7. By the time your fasting glucose is elevated, your insulin has been elevated for YEARS trying to compensate.
Ask your doctor to include fasting insulin in your bloodwork panel. It's cheap (~$20) and incredibly informative.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemCryptoCarl said:Fasting glucose improved within weeks and my HbA1c barely moved for three months, which I now understand and did not at the time.
This is my experience too, for whatever a second data point is worth. I had assumed I was the exception until I read this.
Adding the clinical framing, because it changes how the question reads.
Complete metabolic panel trending on glycaemic control — sharing because comprehensive data helps everyone:
| Test | Baseline | Month 3 | Month 6 | Month 12 |
|---|---|---|---|---|
| Glucose (fasting) | 125 | 107 | 89 | 85 |
| Insulin (fasting) | 21 | 15 | 9 | 5 |
| HOMA-IR | 5.5 | 3.1 | 1.7 | 1.4 |
| Uric Acid | 7.8 | 6.5 | 5.6 | 5.1 |
The insulin resistance improvement (HOMA-IR) is what my endo focuses on most. Going from 5.5 to near 1.0 is a metabolic transformation.